Post-approval studies (Phase 4)Study completedNCT00168857
What this trial is testing
A Prospective, Randomised, Double-blind, Double-dummy, Forced-titration, Multicentre, Parallel Group, One Year Treatment Trial to Compare Telmisartan (MICARDIS) 80 mg Versus Losartan (COZAAR) 100 mg, in Hypertensive Type 2 Diabetic Patients With Overt Nephropathy (AMADEO Study)
Who this might be right for
HypertensionDiabetic Nephropathies
Boehringer Ingelheim 860